Drug Shortage Report for METHOTREXATE SUBCUTANEOUS

Last updated on 2021-02-24 History
Report ID 133083
Drug Identification Number 02491362
Brand name METHOTREXATE SUBCUTANEOUS
Common or Proper name METHOTREXATE SUBCUTANEOUS
Company Name ACCORD HEALTHCARE INC
Market Status MARKETED
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size Vial
ATC code L04AX
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-02-02
Estimated end date
Actual end date 2021-02-23
Shortage status Resolved
Updated date 2021-02-24
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-02-24 French Compare
v8 2021-02-24 English Compare
v7 2021-02-24 French Compare
v6 2021-02-24 English Compare
v5 2021-02-19 French Compare
v4 2021-02-19 English Compare
v3 2021-02-03 English Compare
v2 2021-02-02 French Compare
v1 2021-02-02 English Compare

Showing 1 to 9 of 9